Grants and Contributions:

Back to search
Title:
197861
Agreement Number:
197861
Agreement Value:
$2,944,000.00
Agreement Date:
Sep 15, 2011 - Aug 31, 2013
Description:
Development of DepoVax-based cancer immunotherapies
Organization:
Atlantic Canada Opportunities Agency
Location:
Halifax, Nova Scotia, CA B3H 0A8
Reference Number:
276-2011-2012-Q2-00249
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Additional Information:

The assistance type is Conditionally Repayable Contribution.

Recipient's Legal Name:
ImmunoVaccine Technologies Inc.
Program:
Atlantic Innovation Fund (AIF) - II